NewAmsterdam Pharma Company N.V. (NAMS) Financials
NAMS Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2026 | 732.6 million | 67.4 million |
| Dec. 31, 2025 | 769.3 million | 85.9 million |
| Sept. 30, 2025 | 786.4 million | 58.4 million |
| June 30, 2025 | 815.1 million | 36.6 million |
NAMS Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2026 | -30.6 million | ? |
| Dec. 31, 2025 | -41.0 million | 14.0 million |
| Sept. 30, 2025 | -32.8 million | 15.0 million |
| June 30, 2025 | -37.8 million | 15.2 million |
NAMS Net Income
No data available :(
NAMS Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2026 | 636.1 million | - | - |
| Dec. 31, 2025 | 636.2 million | 66000 | 202000 |
| Sept. 30, 2025 | 702.9 million | 85000 | 266000 |
| June 30, 2025 | 739.2 million | - | 328000 |
NAMS Shares Outstanding
NAMS Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2026 | 38000 | 37.5 million | 23.5 million | - |
| Dec. 31, 2025 | 100000 | 38.6 million | 27.4 million | - |
| Sept. 30, 2025 | 42000 | 31.0 million | 24.5 million | - |
| June 30, 2025 | 88000 | 27.5 million | 27.3 million | - |
NAMS Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2026 | 3.0 million | 500000 |
| Dec. 31, 2025 | 32000 | 59000 |
| Sept. 30, 2025 | 348000 | 64000 |
| June 30, 2025 | 19.1 million | 45000 |
NAMS
Price: $30.60
52 week price:
Earnings Per Share: -1.78 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 3.7 billion